Bausch & Lomb Nears Sale for $9 Billion

Related Link: 

Bausch & Lomb, which is owned by private-equity firm Warburg Pincus, is nearing a deal to sell itself to generic-drug maker Valeant for about $9 billion.

Exxon in Talks With InterOil

Related Link: 

Exxon Mobil is in exclusive talks with InterOil to invest in the latter's gas assets in Papua New Guinea, a move that could cement the impoverished Southeast Asian country's position as a new significant energy exporter.

Google Pushes Into Emerging Markets

Related Link: 

Google is deep into an effort to fund, build and help run wireless networks in emerging markets such as sub-Saharan Africa and Southeast Asia, a move that could connect a billion or more new people to the Internet.

How to Play Stock Splits

Related Link: 

They have long been considered little more than a gimmick. Yet some strategists have found a way to use stock splits to beat the market.

The Great Internship Swap

Related Link: 

Some business owners are trading internships with others, allowing young people to gain valuable experience while bypassing the red tape.

A Second Chance for Second Homes

Related Link: 

While real estate is heating up, there are still plenty of options in many sought-after vacation-home markets. Here's how to find the right property at the right price.

Chile Fines Barrick Gold Over Big Mine Project

Related Link: 

The Chilean government fined Barrick $15.8 million for alleged breaches in environmental controls at its flagship Pascua-Lama mine.

Turkey Moves to Curb Alcohol Sales

Related Link: 

Turkey moved to curb alcohol sales and restrict advertisements in a move likely to deepen outrage among secular Turks who accuse the government of having an Islamist agenda.

Pricey Beef Puts Heat On U.S. Grilling Season

Related Link: 

Here's the beef: Enjoy the Memorial Day grilling, because retail beef prices are widely expected to set new records in coming weeks.

Bausch & Lomb Unit to Pay $33.5 Million to Resolve Charges

Related Link: 

Ista Pharmaceuticals has agreed to pay $33.5 million to resolve charges that it promoted its anti-inflammatory drug Xibrom for unapproved uses in an effort to boost sales, the Justice Department said.

Syndicate content